Synthetic DNA Is Tailored By AI For Future Medicine Research
Researchers at Chalmers University of Technology in Sweden have created synthetic DNA that directs the...
At $3.5M Hemgenix From CSL- uniQure The Costliest Medicine
There is a new medicine that has surpassed Bluebird Bio as the costliest in the...
EMA Develops A Quality Control Group To Aid Drug Development
To support innovative approaches for the development, manufacture, and quality control (QC) of medicines, along...
RVAC Medicines and A*STAR to Build Capabilities for mRNA Production in Singapore
RVAC Medicines Pte. Ltd. (RVAC), a messenger RNA (mRNA) technology platform company incubated by CBC Group, a...
Merck Invests € 290 Million in U.S. Drug Safety Testing Capacity
Merck, a leading science and technology company, invests more than € 290 million in its...
Quadripartite launches a new platform to tackle antimicrobial resistance threat to human and animal...
The Antimicrobial Resistance Multi-Stakeholder Partnership Platform was launched to ensure the growing threats and impacts...
Regeneron and CytomX Announce Strategic Research Collaboration in the Field of Conditional Bispecific Therapeutics...
Regeneron Pharmaceuticals, Inc. and CytomX Therapeutics, Inc. announced a collaboration and licensing agreement to create...
Australia Offers A Nasal Vaccine To Guard Against COVID-19
Researchers from Australia's Centenary Institute and the University of Sydney have created a novel nasal...
Big Pharma May Need To Report State Deals In WHO Crisis
Under new regulations that would oversee a pandemic agreement approved by the World Health Organization,...
In Britain, The ABPI Sets Out A Clear Antimicrobial Goal
The Association of the British Pharmaceutical Industry (ABPI) has reemphasized its message to the industry...
